How to follow official Neuralink updates and verify primary-source claims
Because Neuralink sits at the intersection of frontier medicine and high-profile private tech, viral social media posts routinely distort trial outcomes or impersonate the company. This five-step verification workflow shows how to check any Neuralink headline against official company domains, federal clinical registries, and verified video records.
- Bookmark the five canonical primary sources:
neuralink.com/updates/,neuralink.com/trials/,youtube.com/@neuralink, and ClinicalTrials.gov (NCT06429735&NCT07224256). - Verify that any YouTube clip comes from channel ID
UCLt4d8cACHzrVvAz9gtaARA(@neuralink), which has 44 public uploads as of 30 October 2026. - Distinguish FDA IDE clinical trial permission and Breakthrough Device Designation from commercial FDA approval (which no Neuralink device holds).
- Never trust social posts claiming an 'official Neuralink token drop' or 'guaranteed IPO allocation'.
Step-by-step workflow
- Step 1 of 5
Check the official Neuralink Updates & Trials pages first
Open neuralink.com/updates/ and neuralink.com/trials/ directly in your browser. Every genuine clinical program launch (PRIME, CONVOY, VOICE), participant count update (such as 'Two Years of Telepathy' on 28 Jan 2026), and regulatory milestone (such as Blindsight Breakthrough designation) is published on the neuralink.com domain.
Verification check: If a major 'breakthrough' or 'human vision trial result' is trending on social media but absent from neuralink.com/updates/, treat it as unverified.
- Step 2 of 5
Cross-check the official @neuralink YouTube channel (UCLt4d8cACHzrVvAz9gtaARA)
Verify video clips against https://www.youtube.com/@neuralink or our searchable 44-video archive at /neuralink/videos. Repost accounts frequently splice old 2020–2022 animations with AI voiceovers and label them as 'new 2026 human surgery footage'.
Verification check: Check the original upload date and video ID in our Video Coverage ledger before citing a clip.
- Step 3 of 5
Look up the study protocol on ClinicalTrials.gov
For clinical trial status, eligibility criteria, study sites, and primary outcome measures, search ClinicalTrials.gov for NCT06429735 (The PRIME Study) and NCT07224256 (The VOICE Study).
Verification check: ClinicalTrials.gov lists the exact recruitment status, study locations (e.g., Barrow Neurological Institute), and responsible party.
- Step 4 of 5
Separate FDA trial designations from commercial FDA approval
Read regulatory terminology carefully: an Investigational Device Exemption (IDE) permits human clinical testing; Breakthrough Device Designation expedites FDA review discussions. Neither means a device is FDA-approved for commercial sale.
Verification check: Every official Neuralink page states at the bottom: 'Neuralink devices are investigational and have not received marketing authorization from the U.S. FDA.'
- Step 5 of 5
Verify any stock or token claim against SEC EDGAR and PreStocks' official registry
Neuralink Corp. is a private company and has never issued a cryptocurrency. If you are researching the third-party NEURALINK PreStocks token on Solana, verify that it is issued by PreStocks (not Neuralink) and match the exact 44-character mint PrekqLJvJ3qVdXmBGDiexvwUTF4rLFDa6HWS4HJbw9S.
Verification check: See our dedicated guide on how to inspect NEURALINK PreStocks safely for the full on-chain verification steps.
Official primary-source bookmark table
| Source type | Official URL / identifier | What to verify there |
|---|---|---|
| Company updates & engineering blog | https://neuralink.com/updates/ | Participant counts, surgical milestones (e.g., transdural surgery), and keynote announcements. |
| Clinical Trials & Patient Registry | https://neuralink.com/trials/ | Active trial overviews (PRIME, CONVOY, VOICE) and official patient registry intake. |
| Official YouTube channel | https://www.youtube.com/@neuralink (UCLt4d8cACHzrVvAz9gtaARA) | All 44 official video demonstrations, Shorts, and full progress livestreams. |
| U.S. ClinicalTrials.gov | NCT06429735 (PRIME) · NCT07224256 (VOICE) | Federal protocol registration, inclusion/exclusion criteria, and primary endpoints. |
| StonkBuilder video archive | /neuralink/videos | Searchable index of all 44 official uploads with dates, transcripts, and scope notes. |
Example: verifying a genuine engineering update video
When Neuralink announced its first clinical transdural procedure on 30 June 2026, it published both a written engineering post on neuralink.com/updates/ and an official video (F8p2MamNBgE) on @neuralink naming the clinical partner (UHN Toronto Western Hospital). Below is that primary video record:
Official November 2023 announcement ('Neuralink's Clinical Trial is Open!') illustrating how Neuralink communicates formal trial openings and directs prospective participants to neuralink.com.
Sources checked 30 Oct 2026
Sources and official records
- [1] Neuralink: Official website and investigational device notice ↗ · Verified 30 Oct 2026
- [2] Neuralink: Official Updates & Engineering Blog ↗ · Verified 30 Oct 2026
- [3] Neuralink: Clinical Trials and Patient Registry ↗ · Verified 30 Oct 2026
- [4] Neuralink: Official YouTube Channel (@neuralink, UCLt4d8cACHzrVvAz9gtaARA) ↗ · Verified 30 Oct 2026
- [5] ClinicalTrials.gov: The PRIME Study (NCT06429735) ↗ · Verified 30 Oct 2026
- [6] ClinicalTrials.gov: The VOICE Study for Communication Restoration (NCT07224256) ↗ · Verified 30 Oct 2026
- [7] Neuralink YouTube (2023-11-21): Neuralink’s Clinical Trial ↗ · Verified 30 Oct 2026